179 related articles for article (PubMed ID: 28468826)
21. Neuropilin-1 expression is induced on tolerant self-reactive CD8+ T cells but is dispensable for the tolerant phenotype.
Jackson SR; Berrien-Elliott M; Yuan J; Hsueh EC; Teague RM
PLoS One; 2014; 9(10):e110707. PubMed ID: 25343644
[TBL] [Abstract][Full Text] [Related]
22. Transmembrane domain interactions control biological functions of neuropilin-1.
Roth L; Nasarre C; Dirrig-Grosch S; Aunis D; Crémel G; Hubert P; Bagnard D
Mol Biol Cell; 2008 Feb; 19(2):646-54. PubMed ID: 18045991
[TBL] [Abstract][Full Text] [Related]
23. Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma.
Inoda S; Hirohashi Y; Torigoe T; Nakatsugawa M; Kiriyama K; Nakazawa E; Harada K; Takasu H; Tamura Y; Kamiguchi K; Asanuma H; Tsuruma T; Terui T; Ishitani K; Ohmura T; Wang Q; Greene MI; Hasegawa T; Hirata K; Sato N
J Immunother; 2009 Jun; 32(5):474-85. PubMed ID: 19609239
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of tumor cell migration by LD22-4, an N-terminal fragment of 24-kDa FGF2, is mediated by Neuropilin 1.
Zhang L; Parry GC; Levin EG
Cancer Res; 2013 Jun; 73(11):3316-25. PubMed ID: 23667176
[TBL] [Abstract][Full Text] [Related]
25. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.
Tse BWC; Volpert M; Ratther E; Stylianou N; Nouri M; McGowan K; Lehman ML; McPherson SJ; Roshan-Moniri M; Butler MS; Caradec J; Gregory-Evans CY; McGovern J; Das R; Takhar M; Erho N; Alshalafa M; Davicioni E; Schaeffer EM; Jenkins RB; Ross AE; Karnes RJ; Den RB; Fazli L; Gregory PA; Gleave ME; Williams ED; Rennie PS; Buttyan R; Gunter JH; Selth LA; Russell PJ; Nelson CC; Hollier BG
Oncogene; 2017 Jun; 36(24):3417-3427. PubMed ID: 28092670
[TBL] [Abstract][Full Text] [Related]
26. Human Antibody Domains and Fragments Targeting Neutrophil Elastase as Candidate Therapeutics for Cancer and Inflammation-Related Diseases.
Chu X; Sun Z; Baek DS; Li W; Mellors JW; Shapiro SD; Dimitrov DS
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681796
[TBL] [Abstract][Full Text] [Related]
27. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library.
Liang WC; Dennis MS; Stawicki S; Chanthery Y; Pan Q; Chen Y; Eigenbrot C; Yin J; Koch AW; Wu X; Ferrara N; Bagri A; Tessier-Lavigne M; Watts RJ; Wu Y
J Mol Biol; 2007 Feb; 366(3):815-29. PubMed ID: 17196977
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of neuropilin-1 by RNA-interference and its angiostatic potential in the treatment of hepatocellular carcinoma.
Raskopf E; Vogt A; Standop J; Sauerbruch T; Schmitz V
Z Gastroenterol; 2010 Jan; 48(1):21-7. PubMed ID: 20072992
[TBL] [Abstract][Full Text] [Related]
29. Targeting neuropilin 1 as an antitumor strategy in lung cancer.
Hong TM; Chen YL; Wu YY; Yuan A; Chao YC; Chung YC; Wu MH; Yang SC; Pan SH; Shih JY; Chan WK; Yang PC
Clin Cancer Res; 2007 Aug; 13(16):4759-68. PubMed ID: 17699853
[TBL] [Abstract][Full Text] [Related]
30. Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells.
Peters HL; Tripathi SC; Kerros C; Katayama H; Garber HR; St John LS; Federico L; Meraz IM; Roth JA; Sepesi B; Majidi M; Ruisaard K; Clise-Dwyer K; Roszik J; Gibbons DL; Heymach JV; Swisher SG; Bernatchez C; Alatrash G; Hanash S; Molldrem JJ
Cancer Immunol Res; 2017 Apr; 5(4):319-329. PubMed ID: 28254787
[TBL] [Abstract][Full Text] [Related]
31. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity.
Jia H; Cheng L; Tickner M; Bagherzadeh A; Selwood D; Zachary I
Br J Cancer; 2010 Feb; 102(3):541-52. PubMed ID: 20087344
[TBL] [Abstract][Full Text] [Related]
32. Identification of two novel alternatively spliced Neuropilin-1 isoforms.
Cackowski FC; Xu L; Hu B; Cheng SY
Genomics; 2004 Jul; 84(1):82-94. PubMed ID: 15203206
[TBL] [Abstract][Full Text] [Related]
33. Architecture and hydration of the arginine-binding site of neuropilin-1.
Mota F; Fotinou C; Rana RR; Chan AWE; Yelland T; Arooz MT; O'Leary AP; Hutton J; Frankel P; Zachary I; Selwood D; Djordjevic S
FEBS J; 2018 Apr; 285(7):1290-1304. PubMed ID: 29430837
[TBL] [Abstract][Full Text] [Related]
34. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K
Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444
[TBL] [Abstract][Full Text] [Related]
35. Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer.
Bourbié-Vaudaine S; Blanchard N; Hivroz C; Roméo PH
J Immunol; 2006 Aug; 177(3):1460-9. PubMed ID: 16849452
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
Ishikawa T; Kimura Y; Hirano H; Higashi S
J Biol Chem; 2017 Dec; 292(50):20769-20784. PubMed ID: 29046355
[TBL] [Abstract][Full Text] [Related]
37. A Novel Physiological Glycosaminoglycan-Deficient Splice Variant of Neuropilin-1 Is Anti-Tumorigenic In Vitro and In Vivo.
Hendricks C; Dubail J; Brohée L; Delforge Y; Colige A; Deroanne C
PLoS One; 2016; 11(10):e0165153. PubMed ID: 27798666
[TBL] [Abstract][Full Text] [Related]
38. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
[TBL] [Abstract][Full Text] [Related]
39. Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.
Ghez D; Lepelletier Y; Lambert S; Fourneau JM; Blot V; Janvier S; Arnulf B; van Endert PM; Heveker N; Pique C; Hermine O
J Virol; 2006 Jul; 80(14):6844-54. PubMed ID: 16809290
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice.
Lane AA; Ley TJ
Cell; 2003 Oct; 115(3):305-18. PubMed ID: 14636558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
